Actualités

Le 14 janvier 2017, Karine Chevreul intervient aux journées européennes de la société française de cardiologie. Elle est invitée à y faire une présentation sur l’extension des TAVI aux risques intermédiaires : un progrès qui a un coût ?

Les TAVI sont des bioprothèses valvulaires aortiques implantées par voie transfémorale ou transapicale chez des patients atteints d’un rétrécissement aortique serré.

Karine Chevreul participe également à un projet RHU sur le sujet.

Publications :

- Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation : Results From the FRANCE-2 Registry. Chopard R, Teiger E, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Mouillet G, Schiele F ; FRANCE-2 Investigators. JACC Cardiovasc Interv. 2015 Aug 24 ;8(10):1346-55.
- Comparison of Outcome of Transcatheter Aortic Valve Implantation With Versus Without Previous Coronary Artery Bypass Grafting (from the FRANCE 2 Registry). Castellant P, Didier R, Bezon E, Couturaud F, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Laskar M, Boschat J, Gilard M ; FRANCE 2 Investigators. Am J Cardiol. 2015 Aug 1 ;116(3):420-5.
- Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry). Arai T, Morice MC, O’Connor SA, Yamamoto M, Eltchaninoff H, Leguerrier A, Leprince P, Laskar M, Iung B, Fajadet J, Prat A, Lièvre M, Donzeau-Gouge P, Chevreul K, Teiger E, Lefèvre T, Gilard M ; FRANCE 2 Registry Investigators. Catheter Cardiovasc Interv. 2015 Jun ;85(7):1231-9. doi : 10.1002/ccd.25832.
- Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation : results from the FRANCE 2 registry. Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande JL, Teiger E ; FRANCE 2 Registry investigators. EuroIntervention. 2015 Jan ;10(9):e1-9.
- Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI : an analysis from the FRANCE 2 registry. Amabile N, Agostini H, Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Laskar M, Caussin C. EuroIntervention. 2014 Nov ;10(7):842-9.
- Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia : subanalysis of the French Aortic National CoreValve and Edwards 2 registry. Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande JL, Chopard R, Van Belle E, Otsuka T, Teiger E ; FRANCE 2 Registry Investigators. Circ Cardiovasc Interv. 2014 Aug ;7(4):602-10.
- Predictive factors of early mortality after transcatheter aortic valve implantation : individual risk assessment using a simple score. Iung B, Laouénan C, Himbert D, Eltchaninoff H, Chevreul K, Donzeau-Gouge P, Fajadet J, Leprince P, Leguerrier A, Lièvre M, Prat A, Teiger E, Laskar M, Vahanian A, Gilard M ; FRANCE 2 Investigators. Heart. 2014 Jul ;100(13):1016-23.
- Impact of chronic obstructive pulmonary disease on Valve Academic Research Consortium-defined outcomes after transcatheter aortic valve implantation (from the FRANCE 2 Registry). Chopard R, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Teiger E, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Schiele F. Am J Cardiol. 2014 May 1 ;113(9):1543-9.
- Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry). Yamamoto M, Mouillet G, Oguri A, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Rande JL, Teiger E ; FRANCE 2 Registry Investigators. Am J Cardiol. 2013 Dec 15 ;112(12):1932-7.
- Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Chevreul K, Brunn M, Cadier B, Haour G, Eltchaninoff H, Prat A, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gilard M, Gueret P ; FRANCE registry investigators. Arch Cardiovasc Dis. 2013 Apr ;106(4):209-19.
- Registry of transcatheter aortic-valve implantation in high-risk patients. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M ; FRANCE 2 Investigators. N Engl J Med. 2012 May 3 ;366(18):1705-15.

Dernière mise à jour le 12/01/2017